Bardoxolone (Standard)

CAT: 0804-HY-14909R-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-14909R-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Bardoxolone (Standard) is the analytical standard of Bardoxolone (HY-14909) . This product is intended for research and analytical applications. Bardoxolone is an orally active activator of nuclear regulatory factor (NRf-2) and an inhibitor of SARS-CoV-2 3CL protease. Bardoxolone inhibits SARS-CoV-2 3CL protease with an EC50 value of 0.43 μM in vero cells. Bardoxolone also inhibits necroptosis in HT-29 cells with an EC50 value of 1.30 μM by blocking necrosome formation through inhibiting phosphorylation of RIPK1 and RIPK3. Bardoxolone can be used in research on COVID-19, TNF-induced systemic inflammatory response syndrome (SIRS), and cerebral ischemia-reperfusion injury[1][2].
CAS Number
[218600-44-3]
Product Name Alternative
CDDO (Standard) ; RTA 401 (Standard)
UNSPSC
12352211
Target
Keap1-Nrf2; Necroptosis; Reference Standards; SARS-CoV; Virus Protease
Related Pathways
Anti-infection; Apoptosis; NF-κB; Others
Field of Research
Infection; Inflammation/Immunology; Cardiovascular Disease
Smiles
CC1(C)CC[C@@]2(C(O)=O)[C@@]([C@](C(C=C3[C@@]4(C)CC[C@]5([H])[C@]3(C)C=C(C#N)C(C5(C)C)=O)=O)([H])[C@@]4(C)CC2)([H])C1
Molecular Formula
C31H41NO4
Molecular Weight
491.66
References & Citations
[1]Sun Q, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6 (1) :212.|[2]Wang Y, et al. Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors. Eur J Med Chem. 2021 Feb 15;212:113030.|[3]Yasemin Teksen, et al. Bardoxolone methyl attenuates acetaminophen-induced acute kidney injury by suppressing oxidative stress, inflammation and apoptosis[J]. 2024 May 29;31 (5) :372–379|[4]Kim HK, et al. Bardoxolone Methyl Ameliorates Chemotherapy-Induced Neuropathic Pain by Activation of Phosphorylated Nuclear Factor Erythroid 2-Related Factor 2 in the Dorsal Root Ganglia. Anesth Analg. 2024 Mar 1;138 (3) :664-675.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Clinical Information
No Development Reported

Related Products

CatalogName
HY-14909-01Bardoxolone
HY-13324-01Bardoxolone methyl
HY-W099580R-01Hexadecane (Standard)
HY-W050088R-01Isoxepac (Standard)
HY-N0540R-01Cynaroside (Standard)
HY-115584R-01Lufenuron (Standard)
HY-B0511R-01Biotin (Standard)
HY-13683R-01Mifepristone (Standard)
HY-N0322R-01Cholesterol (Standard)
HY-14654R-01Aspirin (Standard)

Alternative Products

CatalogName
TRC-B118660-1MGBardoxolone
OR1025712-01Bardoxolone Methyl
S6647-25mgBardoxolone (CDDO)

Popular Products